BackAEON Biopharma Overview

AEON Biopharma Total Liabilities

Track AEON Biopharma's total liabilities ($21M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$21.27M
↓ 22.69% YoYΔ $-6.24M vs prior year quarter

Peer trimmed avg / median

Loading

AEON Biopharma Total Liabilities History

Loading

AEON Biopharma vs. peers: Total Liabilities Comparison

Loading

AEON Biopharma Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AEON Biopharma (AEON) FAQ

AEON Biopharma posts a total liabilities of $21M as of June 2026. That compares with $28M in the prior-year period — down 22.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, AEON Biopharma's total liabilities was $28M. The latest reading is $21M — a 22.7% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Total Liabilities is one piece of AEON Biopharma's financial statement story. At $21M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for AEON's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; AEON Biopharma's other metric pages and overview cover the third.